Editas Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

On January 4, 2022, Editas Medicine (Nasdaq: EDIT) announced its participation in the 40th Annual J.P. Morgan Healthcare Conference, scheduled for January 12, 2022, at 10:30 a.m. ET. This virtual event will provide a comprehensive overview of the company and its ongoing projects in genome editing.

A live webcast can be accessed via the Editas Medicine website, with an archived replay available for 30 days post-event. Editas Medicine focuses on leveraging CRISPR technology to develop innovative treatments for serious diseases.

News Market Reaction – EDIT

-4.45%

-4.45% Session move

In the trading session that priced this news, EDIT declined 4.45%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will present a company overview and update at the 40th Annual J.P. Morgan Healthcare Conference, held virtually, on Wednesday, January 12, 2022, at 10:30 a.m. ET

A live webcast of the presentation will be available on the Investors section of the Editas Medicine website at www.editasmedicine.com. An archived replay will be available on the website for approximately 30 days following the presentation.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com. 

Contacts:
Media
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com 

Investors
Ron Moldaver
(617) 401-9052
ir@editasmed.com 

 

FAQ

When is Editas Medicine presenting at the J.P. Morgan Healthcare Conference?

Editas Medicine will present on January 12, 2022, at 10:30 a.m. ET.

Where can I watch the Editas Medicine presentation?

The presentation can be viewed live on the Editas Medicine website in the Investors section.

What is the focus of Editas Medicine?

Editas Medicine specializes in genome editing, utilizing CRISPR technology to develop treatments for serious diseases.

How long will the Editas Medicine presentation be available for replay?

An archived replay of the presentation will be available for approximately 30 days after the event.

What is the stock symbol for Editas Medicine?

The stock symbol for Editas Medicine is EDIT.